Ge, Zhongqi; Leighton, Jake S; Wang, Yumeng; Peng, Xinxin; Chen, Zhongyuan; Chen, Hu; Sun, Yutong; Yao, Fan; Li, Jun; Zhang, Huiwen; Liu, Jianfang; Shriver, Craig D; Hu, Hai; Piwnica-Worms, Helen; Ma, Li; Liang, Han (2018). Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell reports, 23(1), 213-226.e3. Cell Press 10.1016/j.celrep.2018.03.047
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
nihms958976.pdf - Accepted Version Restricted to registered users only Available under License Publisher holds Copyright. Download (2MB) |
|
|
Text
1-s2.0-S2211124718303929-main.pdf - Published Version Available under License Creative Commons: Attribution-Noncommercial-No Derivative Works (CC-BY-NC-ND). Download (5MB) | Preview |
Protein ubiquitination is a dynamic and reversible process of adding single ubiquitin molecules or various ubiquitin chains to target proteins. Here, using multidimensional omic data of 9,125 tumor samples across 33 cancer types from The Cancer Genome Atlas, we perform comprehensive molecular characterization of 929 ubiquitin-related genes and 95 deubiquitinase genes. Among them, we systematically identify top somatic driver candidates, including mutated FBXW7 with cancer-type-specific patterns and amplified MDM2 showing a mutually exclusive pattern with BRAF mutations. Ubiquitin pathway genes tend to be upregulated in cancer mediated by diverse mechanisms. By integrating pan-cancer multiomic data, we identify a group of tumor samples that exhibit worse prognosis. These samples are consistently associated with the upregulation of cell-cycle and DNA repair pathways, characterized by mutated TP53, MYC/TERT amplification, and APC/PTEN deletion. Our analysis highlights the importance of the ubiquitin pathway in cancer development and lays a foundation for developing relevant therapeutic strategies.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie 04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Präzisionsonkologie |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2211-1247 |
Publisher: |
Cell Press |
Language: |
English |
Submitter: |
Marla Rittiner |
Date Deposited: |
09 Oct 2019 08:31 |
Last Modified: |
24 Oct 2019 07:35 |
Publisher DOI: |
10.1016/j.celrep.2018.03.047 |
PubMed ID: |
29617661 |
Additional Information: |
Mark Rubin (Direktor DBMR) ist Collaborator in dieser Publikation. |
Uncontrolled Keywords: |
FBXW7 The Cancer Genome Atlas biomarker cancer prognosis pan-cancer analysis therapeutic targets tumor subtype ubiquitin pathway |
BORIS DOI: |
10.7892/boris.126386 |
URI: |
https://boris.unibe.ch/id/eprint/126386 |
Actions (login required)
 |
Edit item |